Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 33342-210

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 33342-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prami (Pramipexole Structural Formula)

Chemical structure of Pramipexole Dihydrochloride, showing the molecular arrangement including a thiazole ring, amine groups, and dihydrochloride and hydrate components.*

FDA Label Image

666 (Pramipexole 0 375 30s)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.375 mg by Macleods Pharmaceuticals Limited. The label states the tablet strength, extended-release form, and contains 30 tablets per container. It includes storage instructions and usage precautions, highlighting that tablets must be swallowed whole, not chewed or divided.*

FDA Label Image

345 (Pramipexole 0 75 30s)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.75 mg strength. The label indicates once daily oral dosing, packaging contains 30 tablets. Manufactured by Macleods Pharmaceuticals Ltd., India, for Macleods Pharma USA, Inc. The label includes storage instructions and a note that tablets must be swallowed whole.*

FDA Label Image

888 (Pramipexole 1 5 30s)

Pramipexole Dihydrochloride Extended-Release Tablets 1.5 mg, oral dosage form, manufactured by Macleods Pharmaceuticals Ltd and Macleods Pharma USA, Inc. The label indicates a 30-tablet bottle, with instructions to swallow tablets whole and storage conditions at controlled room temperature.*

FDA Label Image

432 (Pramipexole 2 25 30s)

Label for Pramipexole Dihydrochloride Extended-Release Tablets, 2.25 mg, in a 30-tablet unit of use container. The label includes dosage strength and instructions that tablets must be swallowed whole. Manufactured by Macleods Pharmaceuticals Ltd., India, and Macleods Pharma USA, Inc., Princeton, NJ. Storage and handling instructions are provided.*

FDA Label Image

555 (Pramipexole 3 30s)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 3 mg by Macleods Pharmaceuticals. The label indicates the tablets are once daily, extended-release with a 3 mg strength per tablet. The package contains 30 tablets and is labeled for prescription use only. It includes storage instructions, dosage note to swallow whole, and manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd, India.*

FDA Label Image

222 (Pramipexole 3 75 30s)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 3.75 mg by Macleods Pharmaceuticals Limited. The label indicates the tablets are for once daily oral use, with 30 tablets per container. It includes dosage instructions to swallow whole and storage conditions. The label also shows manufacturer details and barcodes.*

FDA Label Image

999 (Pramipexole 4 5 30s)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 4.5 mg, oral dosage form. The label indicates once daily use, dispensed in original unit of use container, with 30 tablets per container. Manufactured by Macleods Pharmaceuticals Ltd and Macleods Pharma USA, Inc. Storage instructions and warnings about swallowing tablets whole and avoiding exposure to humidity are included.*

FDA Label Image

123 (Pramipexole 0 375 10 X10)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.375 mg by Macleods Pharmaceuticals Limited. This prescription medication is available as oral tablets in a unit dose blister pack containing 100 tablets (10 x 10). The label includes storage instructions, dosage form, and manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd, India.*

FDA Label Image

222 (Pramipexole 0 75 10x10)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 0.75 mg by Macleods Pharmaceuticals Limited. The oral tablets are packaged in a unit dose blister pack of 100 (10 x 10) tablets. The label includes dosage strength, manufacturer details, storage instructions, and a barcode.*

FDA Label Image

333 (Pramipexole 1 5 10x10)

Pramipexole Dihydrochloride Extended-Release Tablets, 1.5 mg, unit dose blister pack with 100 tablets (10 x 10). The label includes dosage form as extended-release oral tablets, manufacturer Macleods Pharmaceuticals Limited, and distributor Macleods Pharma USA, Inc. The packaging features storage instructions and a barcode, specifying the tablets are to be swallowed whole and not divided, crushed, or chewed.*

FDA Label Image

888 (Pramipexole 2 25 10x10)

Packaging label for Pramipexole Dihydrochloride Extended-Release Tablets, 2.25 mg strength, by Macleods Pharmaceuticals Limited. The label shows 100 unit dose tablets (10 x 10) with the dosage form as extended-release tablets for oral use. It includes manufacturer and distributor information along with storage instructions and a barcode.*

FDA Label Image

777 (Pramipexole 3 10x10)

Label for Pramipexole Dihydrochloride Extended-Release Tablets 3 mg by Macleods Pharmaceuticals Limited. The label indicates the tablets are oral, extended-release, and packaged in a blister pack of 100 unit dose tablets (10 x 10). It includes storage instructions and a barcode, with manufacturer details from Macleods Pharma USA and manufacturing in India.*

FDA Label Image

556 (Pramipexole 3 75 10x10)

Packaging label for Pramipexole Dihydrochloride Extended-Release Tablets 3.75 mg by Macleods Pharmaceuticals Limited. The label indicates a unit dose blister pack containing 100 tablets (10 x 10). Manufactured for Macleods Pharma USA, Inc. The label includes dosage strength, barcode, storage instructions, and cautions about tablet use and child safety.*

FDA Label Image

665 (Pramipexole 4 5 10x10)

Packaging label for Pramipexole Dihydrochloride Extended-Release Tablets 4.5 mg manufactured by Macleods Pharmaceuticals Limited. The label indicates once daily oral tablets with a package size of 100 unit dose tablets (10 x 10). It is marked for prescription use only and includes storage instructions and manufacturer details for Macleods Pharma USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.